Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Precision Therapeutics
ClinicalTrials.gov Identifier:
NCT01271959
First received: January 5, 2011
Last updated: October 4, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)